Riskpilot← Back to searchSign inGet full accessTRYGVANG AS
ASActiveOrg 989162446Kjekstadveien 20, 3440 RøykenActivities of trust, estate and agency accounts · NACE 6432Est. 20050 employees
Revenue 2024
NOK 0
EBITDA margin
—
+47% vs 2023
Equity ratio
97.5%
Financial strength
Net profit 2024
NOK 3,2M
-12% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -36K | +47% |
| Net profit | NOK 3,2M | -12% |
| Total assets | NOK 24,5M | +9% |
| Equity | NOK 23,9M | +12% |
| Employees | 0 | — |
Legal name
TRYGVANG AS
Org number
989162446
Legal form
Aksjeselskap
NACE code
6432 · Activities of trust, estate and agency accounts
Founded
30. desember 2005
Share capital
NOK 100 116
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene. Styrets leder alene.
Company purpose
Investering, kjøp, salg og forvaltning av eierandeler i andre selskaper og foretak.
Address
Kjekstadveien 20, 3440 Røyken
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −12 | −12 |
| EBITDA | −41 | −63 | −68 | −68 | −36 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −41 | −63 | −68 | −68 | −36 |
| Net financials | 2 384 | 3 360 | −3 057 | 3 639 | 3 193 |
| Profit before tax | 2 343 | 3 297 | −3 125 | 3 572 | 3 157 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 2 343 | 3 297 | −3 125 | 3 572 | 3 157 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 23 281 | 25 078 | 20 452 | 22 524 | 24 481 |
| Equity | 21 781 | 23 578 | 18 952 | 21 324 | 23 881 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 500 | 1 500 | 1 500 | 1 200 | 600 |
| Total debt | 1 500 | 1 500 | 1 500 | 1 200 | 600 |
EBITDA margin
-3608200.0%
This company
15.8%
Market median
-22836809% vs market
20202024
Equity ratio
97.5%
This company
38.2%
Market median
+155% vs market
20202024
Return on equity
13.2%
This company
18.4%
Market median
+28% vs market
20202024
Net profit margin
315659200.0%
This company
8.1%
Market median
+3897027060% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JE Deputy Member | Deputy Member | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2020 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
TRYGVANG AS 
Lion Healthcare Holding AsBoard members of TRYGVANG AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Egil Omsland | Deputy Member | 0 companies |
| Nina Omsland Kjekstad | Chairman | 0 companies |
| Trond Johannes Kjekstad | Board of Directors | 0 companies |